What question did this study set out to answer?

The study aims to determine the occurrence of pyrazinamide-resistant mycobacterium tuberculosis in clinical specimens.

Novel sequence-based assay for detection of pyrazinamide-resistant mycobacterium tuberculosis in clinical specimens from patients with pulmonary tuberculosis in Russia

View Full Paper

Ask AI

Bookmark

Authors

Novel assay identifies pyrazinamide resistance in mycobacterium tuberculosis, suggesting potential for improved patient treatment outcomes.

The study aims to determine the occurrence of pyrazinamide-resistant mycobacterium tuberculosis in clinical specimens.
Developed a diagnostic kit based on direct sequencing of the pncA gene.
Examined 143 respiratory specimens from 140 patients with pulmonary tuberculosis in Russia.
Classified patients into 5 groups based on treatment duration.
Found PZA-resistance in 9 (10.3%) of 87 patients in the first treatment group.
41.6% of patients in the second group showed PZA-resistance.
Detected PZA-resistant strains in 36.8% of patients in the third group and 75.0% in the fourth group.

Figueroa et al. (2011) studied this question.

View Full Paper

Ask AI

Bookmark

Novel assay identifies pyrazinamide resistance in mycobacterium tuberculosis, suggesting potential for improved patient treatment outcomes.